http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112430586-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-107 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-22 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70 |
| filingDate | 2020-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112430586-B |
| titleOfInvention | VI-B type CRISPR/Cas13 gene editing system and application thereof |
| abstract | The invention relates to the technical field of gene editing, in particular to a VI-B type CRISPR/Cas13 gene editing system and application thereof. The VI-B type CRISPR/Cas13 gene editing system comprises an Lt1Cas13B protein and CRISPR RNA; the Lt1Cas13b protein is an RNA endonuclease, and the Lt1Cas13b protein has an amino acid sequence shown in SEQ ID NO. 1 or an amino acid sequence which is at least 80% identical to the amino acid sequence shown in SEQ ID NO. 1. The invention provides a novel VI-B type CRISPR/Cas13 gene editing system, which can be widely applied to the scenes in which prokaryotes or eukaryotes RNA need to be identified, combined and edited and provides a new application choice for an RNA editing tool. |
| priorityDate | 2020-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 544.